Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Hillel Yaffe Medical Center |
---|---|
Information provided by: | Hillel Yaffe Medical Center |
ClinicalTrials.gov Identifier: | NCT00469001 |
To use continuous measurement of NT Pro BNP level as guide in therapy patients with CHF.
Condition | Intervention | Phase |
---|---|---|
Chronic Heart Failure |
Procedure: Treatment according NT Pro BNP level |
Phase I |
Study Type: | Observational |
Study Design: | Natural History, Longitudinal, Random Sample, Prospective Study |
Official Title: | Phase 1 Study of Using BNP as Guided Parameter in Treatment HF |
Estimated Enrollment: | 100 |
Study Start Date: | June 2007 |
Estimated Study Completion Date: | June 2009 |
Group of 100 patients with CHF, NYHA II-IY will be followed for 1 years in outpatient clinic of our hospital for hospitalization, death, 6 min walking protocol, number of decompensation as a primary end point. 50 patients will be treated according usual practice in outpatient clinics and in 50 patients will be additionally used level of NT Pro BNP as additional parameter.If level NT Pro BNP will be goes down will not be changes in treatment regiment. If level of NT Pro BNP will be increased treatment will be intensified.At the end of 1 year follow up we will compare the result of two strategies.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Michael Shochat, MD, PhD | 972 4 6304487 |
Israel | |
Hillel Yaffe Medical Center | |
Hadera, Israel, 38100 |
Principal Investigator: | Michael Shochat, MD, PhD | Hillel Yaffe Medical Center |
Study ID Numbers: | 00001 |
Study First Received: | May 2, 2007 |
Last Updated: | May 2, 2007 |
ClinicalTrials.gov Identifier: | NCT00469001 History of Changes |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Hospitalization and death from exacerbation CHF. |
Death Heart Failure Heart Diseases |
Heart Failure Heart Diseases Cardiovascular Diseases |